The entity has a beta of -0.61, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Tharimmune are expected to decrease at a much lower rate. During the bear market, Tharimmune is likely to outperform the market. At this point, Tharimmune has a negative expected return of -0.0468%. Please make sure to validate Tharimmune's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Tharimmune performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Tharimmune has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tharimmune is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
If you would invest 291.00 in Tharimmune on September 25, 2025 and sell it today you would lose (39.00) from holding Tharimmune or give up 13.4% of portfolio value over 90 days. Tharimmune is currently does not generate positive expected returns and assumes 6.0778% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Tharimmune, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days Tharimmune is expected to under-perform the market. In addition to that, the company is 8.53 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.
Tharimmune Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tharimmune's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tharimmune, and traders can use it to determine the average amount a Tharimmune's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0077
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
THAR
Based on monthly moving average Tharimmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tharimmune by adding Tharimmune to a well-diversified portfolio.
Tharimmune Fundamentals Growth
Tharimmune Stock prices reflect investors' perceptions of the future prospects and financial health of Tharimmune, and Tharimmune fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tharimmune Stock performance.
Assessing Tharimmune's fundamental ratios provides investors with valuable insights into Tharimmune's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tharimmune is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Tharimmune performance evaluation
Checking the ongoing alerts about Tharimmune for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tharimmune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tharimmune generated a negative expected return over the last 90 days
Tharimmune has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (12.2 M) with profit before overhead, payroll, taxes, and interest of 0.
Tharimmune generates negative cash flow from operations
Tharimmune has a frailfinancial position based on the latest SEC disclosures
Evaluating Tharimmune's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Tharimmune's stock performance include:
Analyzing Tharimmune's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tharimmune's stock is overvalued or undervalued compared to its peers.
Examining Tharimmune's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Tharimmune's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tharimmune's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Tharimmune's stock. These opinions can provide insight into Tharimmune's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Tharimmune's stock performance is not an exact science, and many factors can impact Tharimmune's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.